Characterization of the MUC1.Tg/MIN transgenic mouse as a model for studying antigen-specific immunotherapy of adenomas
E T Akporiaye, Katrina T. Trevor(Aurora St. Luke's Medical Center), Pinku Mukherjee(University of North Carolina at Charlotte), David G. Besselsen(University of Arizona), Cathy S. Madsen(Mayo Clinic in Arizona), Haiyan Cui(Tongji University), Sharon M. Dial(University of Arizona), D Bradley-Dunlop(University of Arizona), Tobias Hahn(Providence Portland Medical Center), Sandra Gendler(Mayo Clinic in Arizona)
Cited by 15
Related Papers
MUC1: a multifaceted oncoprotein with a key role in cancer progression
|Trends in Molecular Medicine|2014|854
Non‐erosive reflux disease (NERD) — acid reflux and symptom patterns
|Alimentary Pharmacology & Therapeutics|2003|396
Linking cervicovaginal immune signatures, HPV and microbiota composition in cervical carcinogenesis in non-Hispanic and Hispanic women
|Scientific Reports|2018|290
MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition
|Oncogene|2010|269
Increased expression of thioredoxin-1 in human colorectal cancer is associated with decreased patient survival
|Journal of Laboratory and Clinical Medicine|2003|219